活动报名！医疗器械IPO招股书解读、上市前后传播合规实践

Core Viewpoint - The article emphasizes the importance of the IPO stage for medical device companies, highlighting that these companies often feel hesitant to communicate during this critical period [2]. Summary by Sections IPO Documentation and Communication - The article discusses the contents of the prospectus and the information that can be interpreted and utilized, as well as the communication limitations for companies before and after going public [3]. - It raises questions about the roles of marketing and branding departments during this phase, indicating a lack of systematic guidance and reliance on experiences from investment banks and listing teams [3]. Event Information - An organized event for a small group of participants is scheduled for January 15, 2026, in Shanghai, focusing on IPO-related discussions for medical device companies [4]. - The event is free but requires registration, which will be reviewed [4]. Agenda and Participants - The agenda includes self-introductions, a presentation by a guest speaker, and open discussions, targeting market/brand leaders from companies planning or undergoing IPOs, as well as management and strategic personnel [6]. - The guest speaker will cover three main topics: the readability of medical device prospectuses, compliance boundaries for communication before and after IPO, and executable promotional strategies for companies [7]. Key Topics of Discussion - The article outlines the basic structure and key modules of a prospectus, what different roles (marketing, investment, partners) typically focus on, and the distinction between factual statements and potentially misused content [7]. - It also addresses what can be communicated and what should be avoided, along with common pitfalls in promotional activities [7]. - The differences in risks before and after the IPO stage are highlighted, along with recommendations for effective communication strategies during the IPO process [7].